Jintian Pharmaceutical Group Limited provided earnings guidance for the six months ended June 30, 2014. For the six months, the company expects to record a substantial increase in its consolidated net profit for the six months ended 30 June 2014 as compared to that for the corresponding period in 2013, which is mainly attributable to a substantial growth in both the retail and distribution businesses.